drugset / Trial / NCT02943590

STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)

NCT02943590

RandomizedParallel-groupDouble-blindTreatment

Summary

This research study will test whether atorvastatin, a drug commonly prescribed for reducing cholesterol levels, can protect the heart during chemotherapy with doxorubicin. Atorvastatin is from a family of medications that are commonly called "statins"

Timeline

Start
2017-01-13
Primary completion
2022-09-16
Completion
2023-10-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 40 mg Oral

Indications